148 related articles for article (PubMed ID: 36860864)
1. Research into the characteristic molecules significantly affecting liver cancer immunotherapy.
Chen J; Jin H; Zhou H; Hei X; Liu K
Front Immunol; 2023; 14():1029427. PubMed ID: 36860864
[TBL] [Abstract][Full Text] [Related]
2. High Expression of
Wang Y; Zhao Y; Zhang Z; Zhang J; Xu Q; Zhou X; Mao L
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510310
[No Abstract] [Full Text] [Related]
3. Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma.
Bin X; Luo Z; Wang J; Zhou S
Comput Math Methods Med; 2023; 2023():8958962. PubMed ID: 36785674
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of novel biomarkers affecting bladder cancer immunotherapy
Wang J; He X; Bai Y; Du G; Cai M
Front Immunol; 2022; 13():1051063. PubMed ID: 36439109
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma.
Zhan X; Feng S; Zhou X; Liao W; Zhao B; Yang Q; Tan Q; Shen J
Front Genet; 2022; 13():1047435. PubMed ID: 36386793
[No Abstract] [Full Text] [Related]
6. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm.
Wang T; Dai L; Shen S; Yang Y; Yang M; Yang X; Qiu Y; Wang W
Front Immunol; 2022; 13():843408. PubMed ID: 35693827
[TBL] [Abstract][Full Text] [Related]
8. High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity.
Liu S; Wang Y; Miao C; Xing Q; Wang Z
Cancer Cell Int; 2021 Mar; 21(1):140. PubMed ID: 33648519
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer.
Chen E; Yi J; Jiang J; Zou Z; Mo Y; Ren Q; Lin Z; Lu Y; Zhang J; Liu J
BMC Cancer; 2022 Oct; 22(1):1037. PubMed ID: 36195833
[TBL] [Abstract][Full Text] [Related]
10. Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma.
Liu J; Shen H; Gu W; Zheng H; Wang Y; Ma G; Du J
Front Immunol; 2022; 13():960738. PubMed ID: 36032135
[TBL] [Abstract][Full Text] [Related]
11. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
Chen J; Chen X; Li T; Wang L; Lin G
Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome-based network analysis related to M2-like tumor-associated macrophage infiltration identified VARS1 as a potential target for improving melanoma immunotherapy efficacy.
Wu Z; Lei K; Li H; He J; Shi E
J Transl Med; 2022 Oct; 20(1):489. PubMed ID: 36303162
[TBL] [Abstract][Full Text] [Related]
13. Identification of the alpha linolenic acid metabolism-related signature associated with prognosis and the immune microenvironment in nasopharyngeal carcinoma.
Fang Z; Huang H; Wang L; Lin Z
Front Endocrinol (Lausanne); 2022; 13():968984. PubMed ID: 35992141
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
Cai J; Zhou M; Xu J
World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
[TBL] [Abstract][Full Text] [Related]
16. High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer.
Li S; Huang J; Qin M; Zhang J; Liao C
Mol Med Rep; 2020 Jul; 22(1):57-66. PubMed ID: 32319649
[TBL] [Abstract][Full Text] [Related]
17. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
18. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
19. The Effect of the Histone Chaperones HSPA8 and DEK on Tumor Immunity in Hepatocellular Carcinoma.
Yang C; Shao Y; Wang X; Wang J; Wang P; Huang C; Wang W; Wang J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768989
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]